Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eastman Chemical (EMN) Total Non-Current Liabilities (2016 - 2026)

Eastman Chemical (EMN) has disclosed Total Non-Current Liabilities for 18 consecutive years, with $8.3 billion as the latest value for Q1 2026.

  • For Q1 2026, Total Non-Current Liabilities rose 1.93% year-over-year to $8.3 billion; the TTM value through Mar 2026 reached $8.3 billion, up 1.93%, while the annual FY2025 figure was $7.9 billion, 6.01% down from the prior year.
  • Total Non-Current Liabilities hit $8.3 billion in Q1 2026 for Eastman Chemical, up from $7.9 billion in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $9.1 billion in Q1 2022 and bottomed at $7.9 billion in Q4 2025.
  • Average Total Non-Current Liabilities over 5 years is $8.4 billion, with a median of $8.4 billion recorded in 2023.
  • Year-over-year, Total Non-Current Liabilities fell 7.81% in 2022 and then grew 3.55% in 2024.
  • Eastman Chemical's Total Non-Current Liabilities stood at $8.6 billion in 2022, then dropped by 4.97% to $8.1 billion in 2023, then increased by 3.55% to $8.4 billion in 2024, then fell by 6.01% to $7.9 billion in 2025, then increased by 4.63% to $8.3 billion in 2026.
  • According to Business Quant data, Total Non-Current Liabilities over the past three periods came in at $8.3 billion, $7.9 billion, and $8.1 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.